Prolozone for Musculoskeletal Pain: What It Is, What the Evidence Shows, and Who It Is For
Asare B. Christian, MD, MPH · 2026-11-14
The Direct Answer
Prolozone is an injection treatment that combines ozone gas with a local anesthetic and, in some protocols, B vitamins or other agents, delivered into a joint, tendon, ligament, or painful soft tissue. Small trials and systematic reviews of intra-articular ozone for knee osteoarthritis report short-term improvements in pain and function, but the evidence base is small, heterogeneous, and limited in follow-up. Ozone is not an FDA-approved drug, so prolozone is an unapproved therapy that belongs in a supervised physician practice with informed consent, not in a spa.
What Prolozone Actually Is
The term was popularized by Frank Shallenberger, MD, and describes an injection of medical ozone gas, typically mixed with procaine, into and around a painful structure: a knee or shoulder joint, a tendon insertion, a ligament, or the tissue around a painful spinal segment. Some protocols add B12, sarapin, or other agents borrowed from traditional prolotherapy.
The rationale is different from corticosteroid injection. Rather than suppressing inflammation, ozone acts as a controlled oxidative stimulus. Brief oxidative stress at the injection site is proposed to trigger local repair signaling, improve microcirculation, and modulate inflammatory pathways. That mechanism is biologically plausible and supported by laboratory work, but plausible is not the same as proven in patients.
Two distinctions matter for patients. First, prolozone is not prolotherapy. Prolotherapy uses an irritant solution, typically dextrose, to stimulate connective tissue. Prolozone uses ozone gas, with a different mechanism and a different risk profile. Second, prolozone is not intravenous ozone therapy. Intravenous ozone carries a documented risk of gas embolism and has been the subject of regulatory action. Local injection is a narrower intervention with a different safety picture, though it is not risk-free.
What the Evidence Shows
Knee osteoarthritis has the most data. Multiple small randomized trials and several systematic reviews have examined intra-articular ozone injections for knee osteoarthritis. The general pattern across this literature is short-term improvement in pain scores and function, typically measured at four to twelve weeks, with effects described as comparable to corticosteroids or hyaluronic acid in some trials and superior to placebo in others. A 2024 literature analysis of the ozone and knee osteoarthritis research field concluded that the intervention has a positive short-term effect on pain control and functional recovery within roughly six months of injection.
Ozone therapy is included in the international musculoskeletal literature, not just in integrative circles. Position statements from Italian and other European musculoskeletal societies have addressed oxygen-ozone therapy for spine and joint conditions, which is one reason the literature exists at all. This is not a fringe topic in Europe the way it is in the United States.
Beyond the knee, the evidence thins quickly. For tendinopathy, plantar fasciitis, and low back pain, there are small trials and case series, typically with short follow-up and heterogeneous protocols. Some are encouraging. None are large enough, or consistent enough in design, to make a confident claim about how prolozone compares with physical therapy, corticosteroid injection, or hyaluronic acid.
Methodological limitations are real and worth naming. Sample sizes are small. Ozone concentration and volume vary across studies. Control groups are inconsistent, and blinding a gas injection is difficult. Follow-up rarely extends beyond six months. Publication bias is plausible given how much of this literature originates from a relatively small number of groups. A serious clinician reads this evidence as "promising, not established."
Clinical Interpretation: Where This Fits
In my practice, prolozone is a tool for a specific clinical situation: a patient with a defined structural problem, mild to moderate, who has failed or wants to avoid repeated corticosteroid injections, and who is willing to pair the injection with a loading program. The injection addresses the inflammatory and vascular side of the problem. It does not replace the rehabilitation that restores capacity.
The attraction is real. Corticosteroids are effective but repeated use is associated with cartilage and tendon degradation over time. Hyaluronic acid has modest and inconsistent benefit. Exosomes and unregulated biologics involve cost and, in some cases, regulatory exposure. Prolozone is comparatively inexpensive, minimally invasive, and can be repeated. That combination is why patients ask about it.
The honest framing for a patient is this: this may reduce pain enough for you to do the rehabilitation that actually changes your trajectory. If it works, you will know within four to eight weeks. If it does not, we stop, and we do not repeat a failing intervention because it is convenient.
Limitations and What We Do Not Know
We do not have a large, well-controlled, multi-center trial of prolozone as it is practiced clinically today. We do not know the optimal ozone concentration, the optimal number of injections, or which patients respond. We cannot predict who will get durable relief versus a few weeks of improvement. We do not have long-term safety data on repeated intra-articular ozone.
There is also a regulatory reality patients should understand. The FDA has not approved ozone as a drug for injection, and prolozone is therefore an unapproved therapy. That does not automatically make it unsafe, but it does mean you are relying on the operator's training, the equipment's calibration, and the practice's consent process rather than on a regulatory approval. Any clinic offering ozone injections without medical-grade equipment, calibrated dosing, and a physician performing and supervising the procedure is a clinic to walk out of.
Contraindications and cautions include pregnancy, active infection at the site, bleeding disorders or anticoagulation requiring correction, G6PD deficiency, and uncontrolled hyperthyroidism. Anyone who has been told ozone "has no side effects" is being sold something.
Who This Is Appropriate For
Reasonable candidates include adults with mild to moderate knee osteoarthritis who want to delay or reduce corticosteroid use, patients with localized tendon or ligament pain that has not resolved with loading and rehabilitation, and patients who understand that this is an evidence-limited intervention being used deliberately rather than a guaranteed fix.
Poor candidates include anyone with an active infection, unexplained systemic symptoms, or a structural problem that requires surgical evaluation, such as a mechanical block, a large unstable tear, or progressive neurologic deficit. Also poor candidates: patients looking for a single injection to substitute for the work of rebuilding strength and capacity.
How Aether Medicine Approaches It
Within a physician-led framework, the sequence is diagnosis first. That means a history and physical exam, a functional assessment, and imaging when it will change the plan. We do not inject a joint we have not examined and characterized.
Injection technique uses medical-grade ozone delivered at a calibrated concentration, with sterile technique, ultrasound guidance where the anatomy warrants it, and a documented consent process that names the evidence limits plainly. Prolozone is offered as a component of a plan that includes loading exercise, load management, and metabolic factors that affect healing, including glucose control, sleep, and smoking status. Response is assessed at a defined interval, and non-response is a reason to change course rather than repeat.
Frequently Asked Questions
Is prolozone the same as prolotherapy? No. Prolotherapy uses an irritant such as dextrose to provoke a healing response in connective tissue. Prolozone uses ozone gas, sometimes with additional agents. They are different interventions with different evidence and risk profiles.
Is it FDA approved? No. Ozone is not an FDA-approved drug for injection, which makes prolozone an unapproved therapy. It can be offered lawfully in many states by licensed physicians with appropriate consent, but it is not FDA approved and should be described that way.
How quickly would I know if it worked? Most patients who respond notice meaningful change within two to four weeks, with further improvement by six to eight weeks. If there is no meaningful change by then, repeating the injection is not the right next step.
How does it compare with a cortisone shot? Corticosteroids have stronger and more consistent short-term evidence for pain relief, and a well-known tradeoff with repeated use. Ozone trials suggest comparable short-term relief in some studies, with weaker overall evidence. Neither rebuilds cartilage.
Can it be combined with other treatments? It is commonly combined with physical therapy and load management, and it can be sequenced with other injections. What matters is that each intervention has a defined purpose and a defined endpoint for judging success.
Where can I get an evaluation for joint pain near Philadelphia? Aether Medicine is located at 660 American Ave, #103, King of Prussia, PA 19406, serving the Main Line and Greater Philadelphia. Call 484-806-1101.
References
- Shallenberger F. Prolozone: an advanced treatment for chronic pain and joint disease. Journal of Prolotherapy. Foundational clinical description of the technique and its rationale.
- Systematic reviews and randomized trials of intra-articular ozone injection for knee osteoarthritis, 2015 to 2024, reporting short-term improvements in pain and function with heterogeneous protocols and limited follow-up.
- Literature visualization analysis of ozone therapy for knee osteoarthritis research, 2024, concluding positive short-term effects on pain and function within six months.
- Systematic review of prolotherapy for chronic musculoskeletal pain, distinguishing prolotherapy from ozone-based injection protocols.
- American College of Physicians clinical practice guideline, noninvasive treatments for acute, subacute, and chronic low back pain, for context on established first-line care.
- FDA statements and enforcement actions regarding unapproved ozone therapy, for regulatory context on ozone as a non-approved drug for injection.
This article is educational and does not constitute personal medical advice. Any decision about an injection should be made with a physician who has examined you and reviewed your history.